Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir + Raltegravir in HIV
NCT00752037Phase 4Completed
- Sponsor
- Saint Michael's Medical Center
- Start
- Sep 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir, raltegravir in human immunodeficiency virus infection (HIV), sponsored by Saint Michael's Medical Center. Started Sep 2008; status: completed.
02
Drugs
lopinavir + ritonavirraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00752037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752037.